Article Details

AstraZeneca, CSPC Pharmaceutical Group Reach Exclusive Licensing Agreement to ...

Retrieved on: 2024-10-07 19:06:47

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, CSPC Pharmaceutical Group Reach Exclusive Licensing Agreement to .... View article details on hiswai:

Excerpt

The therapy is in development for the treatment of dyslipidemia and cardiovascular disease, either alone or in combination with AstraZeneca's ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up